Diatron, a Budapest-based manufacturer of medical diagnostic equipment and reagents, inaugurated a new office in New Delhi, India. This strategic expansion into the Asia-Pacific region reflects Diatron’s commitment to growing its presence in emerging markets with high demand for diagnostic products.
The India office provides proximity and timely support to Diatron’s current and future customers in the region. Local operations will allow for improved communication, accelerated project timelines, and more efficient outcomes, the company said.
By establishing local reagent production capabilities, the company aims to create new jobs while better serving the expanding Indian healthcare sector. Peter Zsoka, CFO and Board Director at Diatron, noted that the company will start Indian manufacturing by 2024.
With over 50,000 Diatron analyzers actively used in labs worldwide, the company attributes its continuous growth to strong customer relationships. The new India office marks a milestone in Diatron’s global strategy.
Ronald Backes, VP Sales & Marketing and Board Member of Diatron, said about opening of the office, “We would like to strengthen the partnership with the Asian market, which has always been of significant importance to us. That’s why we proudly opened a new office in the region, to actively contribute to healthcare developments.”
Last updated: December 26th, 2025
